Page 5 - Absorption Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Cell and gene therapy: The next frontier in pharmaceutical services
acs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acs.org Daily Mail and Mail on Sunday newspapers.
Cell and gene therapy services market forecast to see significant growth over the next decade
biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.
Pharmaron takes UK biologics plant off AbbVie s hands
biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.
AbbVie sells biologics plant to Pharmaron, fueling the China company s cell and gene therapy ambitions
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Pharmaron Beijing Co., Limited: Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie
Continues to build integrated capabilities platform for Cell Gene Therapy
Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) ( Pharmaron ) announced today that it has entered into a definitive agreement to acquire Allergan Biologics Limited ( The ABL site ) in Liverpool, UK, for US$118.7 million in cash from AbbVie. The transaction is expected to close in the second quarter of 2021, subject to the satisfaction of customary closing conditions.
The ABL site consists of a state-of-the-art, flexible cGMP biomanufacturing facility located in Liverpool, United Kingdom with over 150 staff. Leveraging the industry-leading expertise in the process R&D, cGMP manufacturing and advanced analytical capabilities in broad range of biologics products, the ABL site has further established a solid foundation and expertise in Cell and Gene Therapy ( CGT ) product d